CORA VILLAGOMEZ: Open Payments
NPI 1356604193 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 17 payments from 5 companies in 2025. Trend: 2023 $242 · 2024 $235 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $213 |
| Lilly USA, LLC | 7 | $116 |
| Becton, Dickinson and Company | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
Products named: Wegovy, MOUNJARO, Exparel.
Industry payments across NE — which companies pay providers there.
